FDA Approved: MOZOBIL — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for Mozobil (plerixafor) filed by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

SUPPL AP for MOZOBIL (PLERIXAFOR)